Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ICUSeaStar Medical Holding Corp

Nasdaq · CIK 0001831868
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC3841 Surgical & Medical Instruments & Apparatus
FY end1231
XBRL facts226

Identity from submissions API

NameSeaStar Medical Holding Corp
CIK0001831868
TickersICU, ICUCW
ExchangesNasdaq, Nasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC3841 Surgical & Medical Instruments & Apparatus
EIN853681132
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone844-427-8100
Website—
Investor website—
Owner org08 Industrial Applications and Services
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • LMF Acquisition Opportunities Inc (2020-12-01T00:00:00.000Z → 2022-10-27T00:00:00.000Z)
Business address
3513 BRIGHTON BLVD
SUITE 410
DENVER
CO
80216
CO
Mailing address
3513 BRIGHTON BLVD
SUITE 410
DENVER
CO
80216
CO

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

550 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-20 8-K FORM 8-K 3.01 0001437749-26-037906 001-39927 261579572 34 186855 1 1
2026-11-17 4 FORM 4 0001437749-26-037445 4512
2026-11-17 4 FORM 4 0001437749-26-037444 4538
2026-11-12 10-Q FORM 10-Q 0001437749-26-036392 001-39927 261543527 34 5922644 1 1
2026-11-12 8-K FORM 8-K 2.02,9.01 0001437749-26-036383 001-39927 261543409 34 460449 1 1
2026-11-10 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-003507 333-299731 261542395 33 1906
2026-11-10 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001213900-26-118160 005-92321 261541833 34 12938
2026-11-03 8-K FORM 8-K 8.01,9.01 0001437749-26-034531 001-39927 261514481 34 222566 1 1
2026-10-30 S-3 REGISTRATION STATEMENT 0001213900-26-114387 333-299731 261508144 33 465896 1 1
2026-10-08 D xslFormDX01/primary_doc.xml 06b 0001831868-26-000002 021-600497 261449138 33 12939
2026-10-05 8-K FORM 8-K 1.01,3.02,8.01,9.01 0001437749-26-032035 001-39927 261440625 34 712940 1 1
2026-08-19 4 FORM 4 0001437749-26-028540 4493
2026-08-12 10-Q FORM 10-Q 0001437749-26-027353 001-39927 261268275 34 5752632 1 1
2026-08-12 8-K FORM 8-K 2.02,9.01 0001437749-26-027314 001-39927 261267577 34 383556 1 1
2026-07-21 S-8 FORM S-8 0001437749-26-023943 333-297591 261190188 33 218069 1 1
2026-07-02 4 FORM 4 - ERIC SCHLORFF RETENTION RSU GRANT 0001437749-26-022573 4828
2026-07-02 4 FORM 4 - KEVIN CHUNG RETENTION RSU GRANT 0001437749-26-022569 4839
2026-07-02 4 FORM 4 - BERNADETTE VINCENT 7-1-26 RSU GRANT 0001437749-26-022567 4711
2026-07-02 4 FORM 4 - JOHN NEUMAN 7-1-2026 RSU GRANT 0001437749-26-022566 4704
2026-07-02 4 FORM 4 0001437749-26-022565 4677
2026-07-02 4 FORM 4 - JENNIFER A. BAIRD 7/1/2026 RSU GRANT 0001437749-26-022559 4705
2026-07-01 8-K FORM 8-K 5.02 0001437749-26-022278 001-39927 261145143 34 249363 1 1
2026-06-23 8-K/A FORM 8-K/A 5.02 0001437749-26-021441 001-39927 261111181 34 186046 1 1
2026-06-17 8-K FORM 8-K 5.02,5.07,9.01 0001437749-26-020967 001-39927 261098393 34 364987 1 1
2026-05-13 424B3 PROSPECTUS 0001213900-26-055905 333-295384 26974339 33 481547
2026-05-13 10-Q FORM 10-Q 0001437749-26-016764 001-39927 26974180 34 5376683 1 1
2026-05-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001213900-26-055826 005-92321 26973686 34 12911
2026-05-13 8-K FORM 8-K 2.02,9.01 0001437749-26-016726 001-39927 26973391 34 353307 1 1
2026-05-11 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001574 333-295384 26965522 33 1905
2026-05-11 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001493152-26-022312 005-92321 26964777 34 11977
2026-05-08 CORRESP filename1.htm 0001213900-26-053656 5556
2026-05-07 S-1/A AMENDMENT NO. 1 TO FORM S-1 0001213900-26-053076 333-295384 26951073 33 573307
2026-05-05 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001490 333-289447 26945571 33 1918
2026-05-05 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001489 333-288065 26945570 33 1918
2026-05-05 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001488 333-268503 26945569 33 1918
2026-05-05 UPLOAD filename1.pdf 0000000000-26-004591 333-295384 148107
2026-04-29 DEF 14A FORM DEF 14A 0001437749-26-013871 001-39927 26916089 34 1722935 1 1
2026-04-28 POS AM POST-EFFECTIVE AMENDMENT NO. 5 TO FORM S-1 0001213900-26-048680 333-268503 26909332 33 517630
2026-04-28 POS AM POST-EFFECTIVE AMENDMENT NO.1 TO FORM S-1 0001213900-26-048679 333-289447 26909330 33 535470
2026-04-28 POS AM POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 0001213900-26-048678 333-288065 26909323 33 526472
2026-04-28 S-1 REGISTRATION STATEMENT 0001213900-26-048608 333-295384 26908730 33 791210 1 1
2026-04-28 8-K FORM 8-K 8.01 0001437749-26-013653 001-39927 26907548 34 186667 1 1
2026-03-25 10-K FORM 10-K 0001437749-26-009797 001-39927 26793175 34 9755914 1 1
2026-03-25 8-K FORM 8-K 2.02,9.01 0001437749-26-009780 001-39927 26792521 34 396193 1 1
2026-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-26-016509 005-92321 26633960 34 13238
2026-02-10 4 FORM 4 - KEN VAN HEEL 2-6-26 RSU GRANT 0001437749-26-003674 4559
2026-02-10 4 FORM 4 - JOHN NEUMAN 2-6-26 RSU GRANT 0001437749-26-003673 12603
2026-02-10 4 FORM 4 - VINCENT BERNADETTE 2-6-26 RSU GRANT 0001437749-26-003672 12906
2026-02-10 4 FORM 4 - JEN BAIRD 2-6-26 RSU GRANT 0001437749-26-003671 4545
2026-02-10 4 FORM 4 - BRAD TOWME 2-6-2026 RSU GRANT 0001437749-26-003670 12988
2026-02-10 4 FORM 4 - KEVIN CHUNG 2-6-26 RSU GRANT 0001437749-26-003669 4692
2026-02-10 4 FORM 4 - ERIC SCHLORFF 2-6-2026 RSU GRANT 0001437749-26-003668 4682
2026-01-20 8-K FORM 8-K 8.01 0001437749-26-001541 001-39927 26542795 34 185616 1 1
2025-12-23 8-K/A FORM 8-K/A 3.03,8.01,9.01 0001437749-25-038701 001-39927 251601307 34 204531 1 1
2025-12-22 4 FORM 4 0001437749-25-038577 12118
2025-12-18 8-K FORM 8-K 3.03,5.07 0001437749-25-038276 001-39927 251583373 34 189398 1 1
2025-12-11 4 FORM 4 0001437749-25-037589 4362
2025-12-08 3 FORM 3 0001437749-25-037172 12563
2025-11-20 424B5 FORM 424B5 0001437749-25-035865 333-275968 251503273 33 22722
2025-11-17 8-K FORM 8-K 5.02 0001437749-25-035449 001-39927 251491700 34 280962 1 1
2025-11-14 DEF 14A PROXY STATEMENT 0001213900-25-110923 001-39927 251487153 34 3678795
2025-11-13 10-Q FORM 10-Q 0001437749-25-034884 001-39927 251479416 34 6550904 1 1
2025-11-13 8-K FORM 8-K 2.02,9.01 0001437749-25-034834 001-39927 251478597 34 414493 1 1
2025-11-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-25-107713 005-92321 251463704 34 13249
2025-11-04 PRE 14A PROXY STATEMENT 0001213900-25-106094 001-39927 251448929 34 4294029
2025-10-14 424B5 PROSPECTUS SUPPLEMENT 0001213900-25-098283 333-275968 251389393 33 327230
2025-09-29 8-K FORM 8-K 5.02 0001437749-25-030023 001-39927 251356456 34 177802 1 1
2025-09-24 8-K 8-K 8.01,9.01 0001193125-25-215608 001-39927 251339310 34 265836 1 1
2025-09-09 3 PRIMARY DOCUMENT 0001214659-25-013560 4437
2025-08-28 4 PRIMARY DOCUMENT 0001214659-25-013006 7353
2025-08-25 4 PRIMARY DOCUMENT 0001213900-25-080440 4865
2025-08-19 8-K 8-K 5.02 0001831868-25-000014 001-39927 251231734 34 187527 1 1
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-003585 005-92321 251222140 34 10733
2025-08-14 8-K/A 8-K/A 2.02,9.01 0001831868-25-000011 001-39927 251214784 34 632295 1 1
2025-08-13 10-Q 10-Q 0001831868-25-000007 001-39927 251212421 34 10699423 1 1
2025-08-13 8-K 8-K 2.01,9.01 0001831868-25-000006 001-39927 251211837 34 624518 1 1
2025-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001641172-25-023319 005-92321 251208911 34 11942
2025-08-12 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002591 333-289447 251208766 33 1906
2025-08-11 CORRESP filename1.htm 0001213900-25-074407 6497
2025-08-11 UPLOAD filename1.pdf 0000000000-25-008406 333-289447 40348
2025-08-08 S-1 REGISTRATION STATEMENT 0001213900-25-073745 333-289447 251199311 33 13030042 1 1
2025-08-08 8-K 8-K 8.01 0000950170-25-105906 001-39927 251198922 34 226020 1 1
2025-08-08 424B5 PROSPECTUS SUPPLEMENT 0001213900-25-073667 333-275968 251198577 33 317023
2025-08-08 S-8 S-8 0000950170-25-105822 333-289421 251198404 33 558010 1 1
2025-08-06 8-K/A 8-K/A 3.01 0000950170-25-103356 001-39927 251186765 34 194798 1 1
2025-08-06 8-K 8-K 3.01 0000950170-25-103274 001-39927 251186459 34 186116 1 1
2025-08-01 8-K 8-K 1.01,3.02,7.01,9.01 0000950170-25-101408 001-39927 251176184 34 1109401 1 1
2025-08-01 424B5 PROSPECTUS SUPPLEMENT 0001213900-25-070322 333-275968 251174171 33 327139
2025-07-16 4 PRIMARY DOCUMENT 0001213900-25-064806 5004
2025-07-16 4 PRIMARY DOCUMENT 0001213900-25-064805 9790
2025-07-16 4 PRIMARY DOCUMENT 0001213900-25-064804 9826
2025-07-16 4 PRIMARY DOCUMENT 0001213900-25-064802 9752
2025-07-16 8-K 8-K 5.02 0000950170-25-096244 001-39927 251127443 34 185398 1 1
2025-07-14 8-K CURRENT REPORT 1.01,3.02,7.01,9.01 0001213900-25-063450 001-39927 251120097 34 1011570 1 1
2025-07-11 424B5 PROSPECTUS SUPPLEMENT 0001213900-25-062972 333-275968 251117588 33 333034
2025-07-10 424B5 PROSPECTUS SUPPLEMENT 0001213900-25-062738 333-275968 251116166 33 10557
2025-07-08 8-K 8-K 5.07 0000950170-25-094442 001-39927 251109498 34 250450 1 1
2025-07-03 4 PRIMARY DOCUMENT 0001213900-25-061522 8295
2025-07-03 4 PRIMARY DOCUMENT 0001213900-25-061521 8609
2025-07-02 4 PRIMARY DOCUMENT 0001213900-25-061153 9717
2025-07-02 8-K 8-K 7.01,8.01,9.01 0000950170-25-093142 001-39927 251102251 34 234912 1 1
2025-06-27 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-25-059101 005-92321 251087721 34 19980
2025-06-27 4 PRIMARY DOCUMENT 0001213900-25-058569 5290
2025-06-23 424B4 PROSPECTUS 0001213900-25-056444 333-288065 251063142 33 2991493
2025-06-23 8-K 8-K 1.01,5.02,7.01,8.01 0000950170-25-088707 001-39927 251062963 34 284413 1 1
2025-06-20 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001984 333-288065 251062839 33 1906
2025-06-20 S-1/A AMENDMENT NO. 1 TO FORM S-1 0001213900-25-055807 333-288065 251059021 33 15568272 1 1
2025-06-17 CORRESP filename1.htm 0001213900-25-055329 5345
2025-06-16 S-1 REGISTRATION STATEMENT 0001213900-25-054502 333-288065 251048623 33 14525173 1 1
2025-06-11 8-K CURRENT REPORT 5.02,9.01 0001213900-25-053463 001-39927 251040404 34 257532 1 1
2025-05-30 UPLOAD filename1.pdf 0000000000-25-005737 377-08040 40595
2025-05-29 424B3 PROSPECTUS 0001213900-25-048983 333-287403 251004406 33 2972975
2025-05-27 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001746 333-287403 25991030 33 1905
2025-05-27 DRS filename1.htm 0001213900-25-047466 377-08040 25983717 33 3127926
2025-05-22 4 PRIMARY DOCUMENT 0001213900-25-046931 5317
2025-05-22 CORRESP filename1.htm 0001213900-25-046925 7331
2025-05-22 UPLOAD filename1.pdf 0000000000-25-005487 333-287403 40332
2025-05-20 4 PRIMARY DOCUMENT 0001213900-25-046119 4864
2025-05-19 S-1 REGISTRATION STATEMENT 0001213900-25-045463 333-287403 25964899 33 14443627 1 1
2025-05-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-002225 005-92321 25951853 34 10537
2025-05-14 10-Q 10-Q 0000950170-25-071583 001-39927 25946858 34 8567854 1 1
2025-05-14 8-K 8-K 2.02,9.01 0000950170-25-071390 001-39927 25945545 34 573011 1 1
2025-05-06 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-25-040244 001-39927 25919524 34 4838700
2025-05-06 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-25-040251 001-39927 25918490 34 3345197
2025-04-29 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001289 333-286677 25890614 33 1905
2025-04-25 PRE 14A PROXY STATEMENT 0001213900-25-035670 001-39927 25875305 34 4842784
2025-04-25 8-K 8-K 1.01,3.02,9.01 0000950170-25-058860 001-39927 25875194 34 920583 1 1
2025-04-25 CORRESP filename1.htm 0001213900-25-035637 6894
2025-04-25 UPLOAD filename1.pdf 0000000000-25-004412 333-286677 40339
2025-04-23 10-K/A 10-K/A 0000950170-25-057332 001-39927 25861379 34 1206440 1 1
2025-04-22 S-3 REGISTRATION STATEMENT 0001213900-25-034232 333-286677 25858212 33 298431
2025-04-22 S-8 S-8 0000950170-25-056721 333-286671 25857724 33 409766
2025-04-03 4 PRIMARY DOCUMENT 0001213900-25-028748 5800
2025-04-03 4 PRIMARY DOCUMENT 0001213900-25-028747 5732
2025-04-02 424B5 PROSPECTUS SUPPLEMENT 0001213900-25-027579 333-275968 25801911 33 11006
2025-03-28 8-K 8-K 5.07 0000950170-25-046827 001-39927 25786668 34 220778 1 1
2025-03-27 10-K 10-K 0000950170-25-046200 001-39927 25780518 34 17220549 1 1
2025-03-27 8-K 8-K 2.02,9.01 0000950170-25-046069 001-39927 25779353 34 512010 1 1
2025-03-21 8-K 8-K 5.07 0000950170-25-043183 001-39927 25760442 34 200858 1 1
2025-03-13 8-K 8-K 8.01 0000950170-25-038314 001-39927 25733753 34 201444 1 1
2025-03-04 DEFR14A PROXY STATEMENT 0001213900-25-020175 001-39927 25704205 34 38411
2025-02-28 DEF 14A PROXY STATEMENT 0001213900-25-018763 001-39927 25689997 34 3382941
2025-02-27 4 PRIMARY DOCUMENT 0001213900-25-017946 11412
2025-02-18 PRE 14A PROXY STATEMENT 0001213900-25-014925 001-39927 25635865 34 3383331
2025-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-25-006352 005-92321 25618985 34 11983
2025-02-03 424B5 PROSPECTUS SUPPLEMENT 0001213900-25-009443 333-275968 25582726 33 332600
2025-02-03 8-K CURRENT REPORT 1.01,3.02,7.01,9.01 0001213900-25-009435 001-39927 25582613 34 942536 1 1
2025-01-31 8-K 8-K 3.01 0000950170-25-011835 001-39927 25579131 34 205891 1 1
2025-01-13 8-K CURRENT REPORT 7.01,8.01,9.01 0001213900-25-002847 001-39927 25524939 34 27724105 1 1
2024-12-26 8-K CURRENT REPORT 3.01 0001213900-24-112673 001-39927 241581266 34 257876 1 1
2024-12-19 8-K 8-K 8.01 0000950170-24-138428 001-39927 241563301 34 197317 1 1
2024-12-03 3 PRIMARY DOCUMENT 0001213900-24-105216 6213
2024-12-03 4 PRIMARY DOCUMENT 0001213900-24-105215 5757
2024-12-03 4 PRIMARY DOCUMENT 0001213900-24-105214 5765
2024-12-03 3 PRIMARY DOCUMENT 0001213900-24-105213 6229
2024-12-03 UPLOAD filename1.pdf 0000000000-24-013311 001-39927 39838
2024-11-27 CORRESP filename1.htm 0000950170-24-131472 41228
2024-11-26 8-K 8-K 5.07 0000950170-24-131042 001-39927 241503807 34 224826 1 1
2024-11-26 UPLOAD filename1.pdf 0000000000-24-013114 001-39927 42855
2024-11-19 4 PRIMARY DOCUMENT 0001213900-24-100248 7322
2024-11-19 4 PRIMARY DOCUMENT 0001213900-24-100246 5790
2024-11-15 4 PRIMARY DOCUMENT 0001213900-24-099150 5721
2024-11-15 4 PRIMARY DOCUMENT 0001213900-24-099149 5709
2024-11-15 4 PRIMARY DOCUMENT 0001213900-24-099147 5730
2024-11-15 4 PRIMARY DOCUMENT 0001213900-24-099146 5723
2024-11-14 SC 13G formsc13g.htm 0001493152-24-046102 005-92321 241464625 34 193359
2024-11-13 10-Q 10-Q 0000950170-24-126498 001-39927 241455702 34 10325205 1 1
2024-11-13 8-K 8-K 2.02,9.01 0000950170-24-126487 001-39927 241455655 34 564999 1 1
2024-11-04 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-24-093753 001-39927 241420790 34 2068364
2024-10-24 PRE 14A PRELIMINARY PROXY STATEMENT 0001213900-24-090400 001-39927 241393027 34 2069330
2024-10-22 8-K CURRENT REPORT 8.01 0001213900-24-089442 001-39927 241384838 34 249788 1 1
2024-10-01 4 PRIMARY DOCUMENT 0001213900-24-084108 5342
2024-09-09 4 PRIMARY DOCUMENT 0001213900-24-077008 6996
2024-09-09 4/A PRIMARY DOCUMENT 0001213900-24-077007 7239
2024-08-27 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-08-27 16:30:00 9999999995-24-002651 333-281220 241250868 33 1913
2024-08-27 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-08-27 16:30:00 9999999995-24-002647 333-280683 241250864 33 1913
2024-08-23 CORRESP filename1.htm 0001213900-24-072225 6776
2024-08-23 CORRESP filename1.htm 0001213900-24-072223 6711
2024-08-21 8-K CURRENT REPORT 1.01,9.01 0001213900-24-071230 001-39927 241226750 34 572733 1 1
2024-08-21 424B5 PROSPECTUS SUPPLEMENT 0001213900-24-071226 333-275968 241226740 33 321688
2024-08-16 S-3/A AMENDMENT NO. 1 TO FORM S-3 0001213900-24-070269 333-280683 241217113 33 278374
2024-08-16 S-3/A AMENDMENT NO. 1 TO FORM S-3 0001213900-24-070268 333-281220 241217112 33 303195
2024-08-13 8-K 8-K 9.01 0000950170-24-096362 001-39927 241202392 34 530557 1 1
2024-08-13 10-Q 10-Q 0000950170-24-096356 001-39927 241202359 34 9472080 1 1
2024-08-07 UPLOAD filename1.pdf 0000000000-24-009023 333-281220 40373
2024-08-02 S-3 REGISTRATION STATEMENT 0001213900-24-064735 333-281220 241170978 33 345198
2024-07-26 D xslFormDX01/primary_doc.xml 06b 0001013762-24-001582 021-519891 241146802 33 14551
2024-07-11 8-K CURRENT REPORT 1.01,3.02,7.01,9.01 0001013762-24-000173 001-39927 241112207 34 885022 1 1
2024-07-11 424B5 PROSPECTUS SUPPLEMENT 0001213900-24-060643 333-275968 241111125 33 390267
2024-07-10 UPLOAD filename1.pdf 0000000000-24-007834 333-280683 40350
2024-07-09 8-K 8-K 8.01 0000950170-24-082415 001-39927 241107613 34 193456 1 1
2024-07-05 8-K 8-K 3.01 0000950170-24-081874 001-39927 241102758 34 199530 1 1
2024-07-03 10-K/A 10-K/A 0000950170-24-081528 001-39927 241100296 34 2154109 1 1
2024-07-03 S-3 REGISTRATION STATEMENT 0001213900-24-059032 333-280683 241100094 33 299855
2024-07-02 8-K 8-K 1.01,9.01 0000950170-24-080011 001-39927 241092907 34 249374 1 1
2024-06-28 8-K 8-K 3.01 0000950170-24-079054 001-39927 241085828 34 200198 1 1
2024-06-14 3 xslF345X02/form3.xml 0000929638-24-002190 9404
2024-06-11 8-K 8-K 8.01 0000950170-24-071622 001-39927 241034649 34 195824 1 1
2024-06-10 8-K 8-K 5.02,9.01 0000950170-24-071087 001-39927 241031547 34 233313 1 1
2024-06-07 8-K 8-K 3.03,5.03 0000950170-24-070915 001-39927 241030759 34 252341 1 1
2024-06-04 8-K 8-K 5.07 0000950170-24-068696 001-39927 241018305 34 231362 1 1
2024-05-14 10-Q 10-Q 0000950170-24-059546 001-39927 24944432 34 8380244 1 1
2024-05-14 8-K 8-K 2.02 0000950170-24-059518 001-39927 24944214 34 464632 1 1
2024-05-09 ARS ARS 0000950170-24-057096 001-39927 24931214 34 2326515
2024-05-03 DEF 14A DEF 14A 0000950170-24-052487 001-39927 24910824 34 3053578
2024-04-26 10-K/A 10-K/A 0000950170-24-049209 001-39927 24884346 34 1090858 1 1
2024-04-23 PRE 14A PRE 14A 0000950170-24-046945 001-39927 24865179 34 3033285
2024-04-18 8-K CURRENT REPORT 5.03,9.01 0000929638-24-001521 001-39927 24852915 34 333784 1 1
2024-04-17 8-K CURRENT REPORT 2.02,9.01 0000929638-24-001513 001-39927 24850937 34 455919 1 1
2024-04-16 4 xslF345X05/form4.xml 0000929638-24-001502 5159
2024-04-16 4 xslF345X05/form4.xml 0000929638-24-001500 4717
2024-04-16 4 xslF345X05/form4.xml 0000929638-24-001498 4757
2024-04-16 4 xslF345X05/form4.xml 0000929638-24-001496 4759
2024-04-16 4 xslF345X05/form4.xml 0000929638-24-001494 4747
2024-04-16 4 xslF345X05/form4.xml 0000929638-24-001492 4760
2024-04-16 4 xslF345X05/form4.xml 0000929638-24-001490 4724
2024-04-16 10-K 10-K 0000950170-24-044855 001-39927 24848607 34 27624599 1 1
2024-04-01 NT 10-K NT 10-K 0000950170-24-038844 001-39927 24805415 34 82550
2024-03-27 8-K/A 8-K/A 8.01 0000950170-24-037363 001-39927 24792074 34 249170 1 1
2024-03-27 8-K 8-K 4.02 0000950170-24-036837 001-39927 24785929 34 223648 1 1
2024-03-27 8-K 8-K 8.01 0000950170-24-036835 001-39927 24785923 34 234940 1 1
2024-03-08 8-K CURRENT REPORT 8.01 0000929638-24-000950 001-39927 24732314 34 209516 1 1
2024-03-05 424B3 PROSPECTUS SUPPLEMENT NO. 35 0000929638-24-000919 333-268503 24722128 33 71442
2024-03-05 424B3 PROSPECTUS SUPPLEMENT NO. 34 0000929638-24-000918 333-268503 24722111 33 42560
2024-03-05 424B3 PROSPECTUS SUPPLEMENT NO. 33 0000929638-24-000917 333-268503 24722090 33 45335
2024-03-05 424B3 PROSPECTUS SUPPLEMENT NO. 32 0000929638-24-000916 333-268503 24722074 33 774547
2024-03-05 424B3 PROSPECTUS SUPPLEMENT NO. 31 0000929638-24-000915 333-268503 24722067 33 43923
2024-03-05 424B3 PROSPECTUS SUPPLEMENT NO. 30 0000929638-24-000914 333-268503 24722047 33 44056
2024-03-05 424B3 PROSPECTUS SUPPLEMENT NO. 29 0000929638-24-000913 333-268503 24722031 33 157410
2024-03-05 424B3 PROSPECTUS SUPPLEMENT NO. 28 0000929638-24-000912 333-268503 24722016 33 27995
2024-03-05 424B3 PROSPECTUS SUPPLEMENT NO. 27 0000929638-24-000911 333-268503 24721999 33 27004
2024-03-05 424B3 PROSPECTUS SUPPLEMENT NO. 26 0000929638-24-000910 333-268503 24721984 33 27258
2024-03-05 424B3 PROSPECTUS SUPPLEMENT NO. 25 0000929638-24-000909 333-268503 24721968 33 26854
2024-03-05 424B3 PROSPECTUS SUPPLEMENT NO. 24 0000929638-24-000908 333-268503 24721934 33 30272
2024-03-05 424B3 PROSPECTUS SUPPLEMENT NO. 23 0000929638-24-000907 333-268503 24721900 33 26694
2024-03-05 424B3 PROSPECTUS SUPPLEMENT NO. 22 0000929638-24-000906 333-268503 24721888 33 194501
2024-03-05 424B3 PROSPECTUS SUPPLEMENT NO. 21 0000929638-24-000905 333-268503 24721843 33 835087
2024-03-05 424B3 PROSPECTUS SUPPLEMENT NO. 20 0000929638-24-000904 333-268503 24721806 33 58431
2024-02-22 8-K 8-K 8.01,9.01 0000950170-24-018440 001-39927 24662357 34 224113 1 1
2024-02-16 8-K 8-K 1.02 0000950170-24-016160 001-39927 24645828 34 186458 1 1
2024-02-14 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-02-14 16:00:00 9999999995-24-000466 333-276675 24641909 33 1912
2024-02-14 SC 13G/A cohenco-icu123123a3.htm 0001172661-24-000983 005-92321 24633305 34 136032
2024-02-12 CORRESP filename1.htm 0000929638-24-000521 7064
2024-02-09 S-8 s8.htm 0000929638-24-000499 333-276978 24615297 33 72449
2024-02-09 S-3/A seastar_s3.htm 0000929638-24-000497 333-276675 24615242 33 340269
2024-02-09 CORRESP filename1.htm 0000929638-24-000495 40451
2024-02-09 8-K 8-K 3.01 0000950170-24-013257 001-39927 24614728 34 191804 1 1
2024-02-02 UPLOAD filename1.pdf 0000000000-24-001339 333-276675 45873
2024-01-30 424B5 seastar_424b5.htm 0000929638-24-000286 333-275968 24576399 33 364321
2024-01-30 8-K CURRENT REPORT 1.01,3.02,8.01,9.01 0000929638-24-000283 001-39927 24576057 34 1169640 1 1
2024-01-24 8-K a8k.htm 8.01 0000929638-24-000189 001-39927 24556983 34 207451 1 1
2024-01-24 S-3 seastar_s3.htm 0000929638-24-000188 333-276675 24556805 33 394089
2024-01-22 3 xslF345X02/form3.xml 0000929638-24-000170 9031
2024-01-12 8-K a8k.htm 8.01 0000929638-24-000095 001-39927 24532627 34 207705 1 1
2024-01-11 8-K a8k.htm 5.02,9.01 0000929638-24-000084 001-39927 24529360 34 351447 1 1
2023-12-29 8-K 8-K 3.01 0000950170-23-073838 001-39927 231527767 34 195483 1 1
2023-12-22 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-12-22 16:00:00 9999999995-23-003730 333-275968 231511238 33 1913
2023-12-20 CORRESP filename1.htm 0000929638-23-003462 6338
2023-12-20 8-K 8-K 8.01 0000950170-23-071791 001-39927 231500320 34 192610 1 1
2023-12-19 UPLOAD filename1.pdf 0000000000-23-013858 40503
2023-12-13 8-K 8-K 3.01 0000950170-23-069889 001-39927 231483068 34 195244 1 1
2023-12-11 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-12-11 17:00:00 9999999995-23-003591 333-275844 231479866 33 1841
2023-12-11 S-3/A seastar_s3a.htm 0000929638-23-003408 333-275844 231478027 33 402404
2023-12-11 8-K 8-K 8.01 0000950170-23-069205 001-39927 231477027 34 194272 1 1
2023-12-08 S-3 seastar_s3.htm 0000929638-23-003406 333-275968 231476113 33 330296
2023-12-07 S-3/A seastar_s3a.htm 0000929638-23-003385 333-275844 231471836 33 38664
2023-12-07 CORRESP filename1.htm 0000929638-23-003386 6378
2023-12-06 UPLOAD filename1.pdf 0000000000-23-013308 40524
2023-12-01 S-3 seastar_s3.htm 0000929638-23-003319 333-275844 231459539 33 369885
2023-11-29 4 xslF345X05/form4.xml 0000929638-23-003302 9006
2023-11-29 4 xslF345X05/form4.xml 0000929638-23-003301 6042
2023-11-29 4 xslF345X05/form4.xml 0000929638-23-003300 12013
2023-11-29 8-K a8k.htm 4.01,9.01 0000929638-23-003299 001-39927 231452258 34 218072 1 1
2023-11-28 4/A xslF345X05/form4.xml 0000929638-23-003235 7015
2023-11-28 4/A xslF345X05/form4.xml 0000929638-23-003234 9354
2023-11-28 4/A xslF345X05/form4.xml 0000929638-23-003233 9348
2023-11-27 4 xslF345X05/form4.xml 0000929638-23-003222 7342
2023-11-27 8-K 8-K 8.01 0000950170-23-066040 001-39927 231437353 34 193890 1 1
2023-11-22 8-K 8-K 2.02,9.01 0000950170-23-065623 001-39927 231429460 34 443553 1 1
2023-11-14 10-Q 10-Q 0000950170-23-063668 001-39927 231405553 34 7892072 1 1
2023-10-30 8-K 8-K 8.01,9.01 0000950170-23-056127 001-39927 231357383 34 241832 1 1
2023-10-26 RW seastar_rw.htm 0000929638-23-002906 333-274413 231350448 NE 5584
2023-10-06 424B3 424B3 0000950170-23-052323 333-271215 231313502 33 98559
2023-10-06 424B3 424B3 0000950170-23-052321 333-268503 231313493 33 99193
2023-10-06 424B3 424B3 0000950170-23-052318 333-273359 231313492 33 98308
2023-10-06 424B3 424B3 0000950170-23-052313 333-269338 231313459 33 98579
2023-10-03 8-K 8-K 8.01,9.01 0000950170-23-051514 001-39927 231303580 34 242113 1 1
2023-09-27 424B3 424B3 0001193125-23-243004 333-269338 231281755 33 23800
2023-09-27 424B3 424B3 0001193125-23-243003 333-271215 231281753 33 23497
2023-09-27 424B3 424B3 0001193125-23-242997 333-268503 231281744 33 23734
2023-09-27 424B3 424B3 0001193125-23-242995 333-273359 231281741 33 23134
2023-09-26 8-K FORM 8-K 8.01 0001193125-23-242074 001-39927 231277670 34 187632 1 1
2023-09-26 424B3 424B3 0001193125-23-241796 333-268503 231277108 33 28815
2023-09-26 424B3 424B3 0001193125-23-241793 333-273359 231277105 33 28152
2023-09-26 424B3 424B3 0001193125-23-241790 333-269338 231277104 33 28857
2023-09-26 424B3 424B3 0001193125-23-241786 333-271215 231277102 33 28559
2023-09-20 8-K 8-K 5.03,9.01 0000950170-23-049027 001-39927 231267175 34 224000 1 1
2023-09-19 4 xslF345X05/form4.xml 0000929638-23-002569 9281
2023-09-19 4 xslF345X05/form4.xml 0000929638-23-002568 6027
2023-09-19 4 xslF345X05/form4.xml 0000929638-23-002567 8962
2023-09-14 424B3 FORM 424(B)(3) 0001193125-23-235383 333-273359 231255809 33 28794
2023-09-14 424B3 FORM 424(B)(3) 0001193125-23-235378 333-271215 231255778 33 29146
2023-09-14 424B3 FORM 424(B)(3) 0001193125-23-235373 333-268503 231255747 33 29522
2023-09-14 424B3 FORM 424(B)(3) 0001193125-23-235369 333-269338 231255727 33 29402
2023-09-12 4 xslF345X05/form4.xml 0000929638-23-002515 6027
2023-09-12 4 xslF345X05/form4.xml 0000929638-23-002513 8962
2023-09-12 4 xslF345X05/form4.xml 0000929638-23-002511 9281
2023-09-12 424B3 424B3 0001193125-23-232818 333-273359 231248936 33 38146
2023-09-12 424B3 424B3 0001193125-23-232817 333-269338 231248935 33 38753
2023-09-12 424B3 424B3 0001193125-23-232815 333-268503 231248920 33 38883
2023-09-12 424B3 424B3 0001193125-23-232814 333-271215 231248919 33 38514
2023-09-08 8-K 8-K 5.07 0000950170-23-047226 001-39927 231244874 34 240499 1 1
2023-09-08 S-1 S-1 0000950170-23-047179 333-274413 231244395 33 20019341 1 1
2023-08-30 8-K 8-K 1.01,2.03,3.02,9.01 0000950170-23-045472 001-39927 231225716 34 260213 1 1
2023-08-24 8-K 8-K 7.01,9.01 0000950170-23-044423 001-39927 231202950 34 11653350 1 1
2023-08-24 DEF 14A DEF 14A 0000950170-23-044188 001-39927 231198441 34 2083190
2023-08-17 4 xslF345X05/form4.xml 0000929638-23-002302 4614
2023-08-17 4 xslF345X05/form4.xml 0000929638-23-002301 4637
2023-08-17 4 xslF345X05/form4.xml 0000929638-23-002300 4589
2023-08-15 424B3 FORM 424(B)(3) 0001193125-23-213490 333-269338 231175475 33 492123
2023-08-15 424B3 FORM 424(B)(3) 0001193125-23-213487 333-268503 231175454 33 492193
2023-08-15 424B3 FORM 424(B)(3) 0001193125-23-213486 333-273359 231175442 33 491514
2023-08-15 424B3 FORM 424(B)(3) 0001193125-23-213484 333-271215 231175415 33 491831
2023-08-15 424B3 424B3 0001193125-23-212899 333-273359 231173143 33 114858
2023-08-15 424B3 424B3 0001193125-23-212898 333-269338 231173142 33 115512
2023-08-15 424B3 424B3 0001193125-23-212896 333-273359 231173137 33 29799
2023-08-15 424B3 424B3 0001193125-23-212890 333-268503 231173130 33 115543
2023-08-15 424B3 424B3 0001193125-23-212885 333-271215 231173118 33 115221
2023-08-15 8-K 8-K 2.02,9.01 0000950170-23-042572 001-39927 231172615 34 502318 1 1
2023-08-14 10-Q 10-Q 0000950170-23-042517 001-39927 231171744 34 8291582 1 1
2023-08-14 PRE 14A PRE 14A 0000950170-23-042485 001-39927 231171209 34 2060158
2023-08-14 424B3 424B3 0001193125-23-212354 333-268503 231170422 33 29393
2023-08-14 424B3 424B3 0001193125-23-212337 333-269338 231170255 33 29392
2023-08-14 424B3 424B3 0001193125-23-212317 333-271215 231170062 33 29097
2023-08-10 424B7 seastar_424b7.htm 0000929638-23-002205 333-273359 231159115 33 2410098
2023-08-10 SC 13G/A cohenco-icu073123a2.htm 0001172661-23-002880 005-92321 231158363 34 136806
2023-08-08 8-K 8-K 1.01,2.03,3.02,9.01 0000950170-23-039280 001-39927 231149026 34 541087 1 1
2023-08-02 8-K 8-K 4.01,9.01 0000950170-23-037198 001-39927 231135935 34 228785 1 1
2023-07-31 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2023-07-31 16:05:00 9999999995-23-002231 333-273359 231129433 33 1841
2023-07-27 CORRESP filename1.htm 0001193125-23-196191 6116
2023-07-27 UPLOAD filename1.pdf 0000000000-23-008034 40474
2023-07-20 S-1 FORM S-1 0001193125-23-190551 333-273359 231100488 33 10399135 1 1
2023-07-05 424B3 424B3 0001193125-23-182063 333-271215 231070822 33 31806
2023-07-05 424B3 424B3 0001193125-23-182056 333-268503 231070784 33 32105
2023-07-05 424B3 424B3 0001193125-23-182052 333-269338 231070754 33 32075
2023-06-30 8-K 8-K 3.01,5.07 0000950170-23-031161 001-39927 231062617 34 245713 1 1
2023-06-27 4 xslF345X04/form4.xml 0000929638-23-001847 9415
2023-06-21 424B3 FORM 424(B)(3) 0001193125-23-170964 333-268503 231028700 33 23423
2023-06-21 424B3 FORM 424(B)(3) 0001193125-23-170961 333-271215 231028686 33 23060
2023-06-21 424B3 FORM 424(B)(3) 0001193125-23-170959 333-269338 231028679 33 23353
2023-06-16 8-K a8k.htm 3.01 0000929638-23-001741 001-39927 231020865 34 204997 1 1
2023-06-13 4 xslF345X04/form4.xml 0000929638-23-001717 11075
2023-06-12 424B3 424B3 0001193125-23-165288 333-271215 231008127 33 22605
2023-06-12 424B3 424B3 0001193125-23-165279 333-268503 231008102 33 22891
2023-06-12 424B3 424B3 0001193125-23-165272 333-269338 231008008 33 22896
2023-06-09 8-K a8k.htm 1.01 0000929638-23-001704 001-39927 231005145 34 203578 1 1
2023-06-05 ARS ARS 0001193125-23-160242 001-39927 23991158 34 1020073
2023-06-01 4 xslF345X04/form4.xml 0000929638-23-001625 10335
2023-05-30 4 xslF345X04/form4.xml 0000929638-23-001610 5931
2023-05-23 424B3 FORM 424(B)(3) 0001193125-23-151958 333-269338 23949947 33 106274
2023-05-23 424B3 FORM 424(B)(3) 0001193125-23-151953 333-268503 23949912 33 106225
2023-05-23 424B3 FORM 424(B)(3) 0001193125-23-151938 333-271215 23949874 33 105987
2023-05-22 4 xslF345X04/form4.xml 0000929638-23-001544 6039
2023-05-19 424B3 FORM 424(B)(3) 0001193125-23-149495 333-268503 23941460 33 398254
2023-05-19 424B3 FORM 424(B)(3) 0001193125-23-149491 333-269338 23941452 33 398167
2023-05-19 424B3 FORM 424(B)(3) 0001193125-23-149490 333-271215 23941451 33 397689
2023-05-19 DEFA14A DEFA14A 0000950170-23-023179 001-39927 23938904 34 1941890
2023-05-19 DEF 14A DEF 14A 0000950170-23-023176 001-39927 23938881 34 2944603
2023-05-16 8-K FORM 8-K 2.02,9.01 0001193125-23-146082 001-39927 23927480 34 286368 1 1
2023-05-15 10-Q 10-Q 0000950170-23-022267 001-39927 23923676 34 7459403 1 1
2023-05-10 424B3 FORM 424(B)(3) 0001193125-23-140880 333-269338 23907736 33 40341
2023-05-10 424B3 FORM 424(B)(3) 0001193125-23-140867 333-271215 23907714 33 40012
2023-05-10 424B3 FORM 424(B)(3) 0001193125-23-140866 333-268503 23907683 33 40393
2023-05-09 8-K 8-K 8.01,9.01 0001193125-23-139508 001-39927 23903143 34 213912 1 1
2023-05-09 PRE 14A PRE 14A 0000950170-23-018945 001-39927 23899157 34 930787
2023-05-05 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-23-130418,2023-05-05 9999999995-23-001310 333-269338 23895711 33 1853
2023-05-05 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-23-130384,2023-05-05 9999999995-23-001308 333-268503 23895707 33 1853
2023-05-04 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-23-130461,2023-05-04 9999999995-23-001295 333-271215 23891038 33 1853
2023-05-01 POS AM POS AM 0001193125-23-130461 333-271215 23873872 33 1837977
2023-05-01 POS AM POS AM 0001193125-23-130418 333-269338 23873743 33 9636994 1 1
2023-05-01 POS AM POS AM 0001193125-23-130384 333-268503 23873599 33 9631964 1 1
2023-04-28 10-K/A 10-K/A 0000950170-23-015649 001-39927 23863532 34 1140052 1 1
2023-04-26 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2023-04-26 16:05:00 9999999995-23-001060 333-271215 23851557 33 1840
2023-04-24 CORRESP filename1.htm 0001193125-23-112862 6269
2023-04-24 S-1/A FORM S-1/A 0001193125-23-112845 333-271215 23840127 33 8831117 1 1
2023-04-21 CORRESP filename1.htm 0001193125-23-110633 17234
2023-04-21 POS AM POS AM 0001193125-23-110619 333-269338 23836936 33 9631982 1 1
2023-04-21 CORRESP filename1.htm 0001193125-23-110604 17278
2023-04-21 POS AM POS AM 0001193125-23-110592 333-268503 23836810 33 9636584 1 1
2023-04-19 UPLOAD filename1.pdf 0000000000-23-003935 40448
2023-04-17 UPLOAD filename1.pdf 0000000000-23-003782 44306
2023-04-17 UPLOAD filename1.pdf 0000000000-23-003780 44317
2023-04-11 S-1 FORM S-1 0001193125-23-097940 333-271215 23813960 33 1892603
2023-04-10 4 xslF345X04/form4.xml 0000929638-23-001153 13727
2023-04-10 4 xslF345X04/form4.xml 0000929638-23-001152 10090
2023-04-10 4 xslF345X04/form4.xml 0000929638-23-001151 9771
2023-04-10 4 xslF345X04/form4.xml 0000929638-23-001150 8398
2023-04-10 4 xslF345X04/form4.xml 0000929638-23-001149 8385
2023-04-10 4 xslF345X04/form4.xml 0000929638-23-001148 8396
2023-04-10 4 xslF345X04/form4.xml 0000929638-23-001147 6743

Latest XBRL company facts

One latest value per concept from companyfacts (226 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 5.32M 2026-11-01 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
dei EntityPublicFloat Entity Public Float USD 7.30M 2025-06-30 2025 FY 10-K 2026-03-25 0001437749-26-009797
ffd NetFeeAmt NetFeeAmt USD 413.64 2026-10-27 S-3 2026-10-30 0001213900-26-114387
ffd TtlFeeAmt TtlFeeAmt USD 413.64 2026-10-27 S-3 2026-10-30 0001213900-26-114387
ffd TtlOfferingAmt TtlOfferingAmt USD 4.75M 2026-10-27 S-3 2026-10-30 0001213900-26-114387
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-10-27 S-3 2026-10-30 0001213900-26-114387
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-10-27 S-3 2026-10-30 0001213900-26-114387
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 1.87M 2022-09-30 2022 Q3 10-Q 2022-11-14 0001193125-22-284622
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 1.47M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap AccountsReceivableGross Accounts Receivable, before Allowance for Credit Loss USD 180,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap AccountsReceivableGrossCurrent Accounts Receivable, before Allowance for Credit Loss, Current USD 225,000 2025-06-30 2025 Q2 10-Q 2025-08-13 0001831868-25-000007
us-gaap AccountsReceivableNet Accounts Receivable, after Allowance for Credit Loss USD 178,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 178,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap AccruedBonusesCurrent Accrued Bonuses, Current USD 625,000 2025-06-30 2025 Q2 10-Q 2025-08-13 0001831868-25-000007
us-gaap AccruedBonusesCurrentAndNoncurrent Accrued Bonuses USD 999,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 3.37M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap AccruedLiabilitiesCurrentAndNoncurrent Accrued Liabilities USD 3.37M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 42,000 2024-09-30 2024 Q3 10-Q 2024-11-13 0000950170-24-126498
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 163.96M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 163,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 56,000 2024-04-01 2024-06-30 2024 Q3 10-Q 2024-11-13 0000950170-24-126498
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 155,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 2,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 2,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) USD 1,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-16 0000950170-24-044855
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 16,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 2.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap Assets Assets USD 5.31M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap AssetsCurrent Assets, Current USD 4.97M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 105.58M 2021-06-30 2021 Q2 10-Q 2021-08-16 0001564590-21-044716
us-gaap AssetsHeldInTrustCurrent Assets Held-in-trust, Current USD 107.05M 2022-09-30 2022 Q3 10-Q 2022-11-14 0001193125-22-284622
us-gaap AssetsHeldInTrustNoncurrent Assets Held-in-trust, Noncurrent USD 105.58M 2021-12-31 2021 FY 10-K 2022-04-06 0001564590-22-013725
us-gaap BusinessCombinationAcquisitionRelatedCosts Business Combination, Acquisition Related Costs USD 2.45M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001193125-22-284622
us-gaap Cash Cash USD 3.99M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 51,567 2021-12-31 2021 FY 10-K 2022-04-06 0001564590-22-013725
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 127,452 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-17 0001564590-21-057476
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 0 2022-09-30 2022 Q3 10-Q 2022-11-14 0001193125-22-284622
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 6.30M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001831868-25-000007
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 3.99M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 4.48M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001831868-25-000007
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -7.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 11.5 2024-06-07 2025 Q2 10-Q 2025-08-13 0001831868-25-000007
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 21,682 2024-01-26 2024 Q2 10-Q 2024-08-13 0000950170-24-096356
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 16.79B 2024-06-07 2025 Q2 10-Q 2025-08-13 0001831868-25-000007
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 425.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 4.46M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 4.46M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap CommonStockValue Common Stock, Value, Issued USD 4,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 0 2025-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 0 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046200
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 438,000 2024-06-30 2024 Q2 10-Q 2024-08-13 0000950170-24-096356
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 0 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001437749-25-034884
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 2.40M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011035
us-gaap ConvertibleDebt Convertible Debt USD 0 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046200
us-gaap ConvertibleDebtCurrent Convertible Debt, Current USD 0 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046200
us-gaap ConvertibleDebtNoncurrent Convertible Debt, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046200
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 148,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 3,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046200
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 10.32M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046200
us-gaap DebtConversionOriginalDebtAmount1 Debt Conversion, Original Debt, Amount USD 0 2024-07-01 2024-09-30 2024 Q3 10-Q 2024-11-13 0000950170-24-126498
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 525,000 2025-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 350 2024-01-24 2024 FY 10-K 2025-03-27 0000950170-25-046200
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 100,000 2020-06-30 2023 FY 10-K 2024-04-16 0000950170-24-044855
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.038 2020-06-30 2023 FY 10-K 2024-04-16 0000950170-24-044855
us-gaap DebtInstrumentPeriodicPayment Debt Instrument, Periodic Payment USD 3,000 2020-06-01 2020-06-30 2023 FY 10-K 2024-04-16 0000950170-24-044855
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 3.76M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-24 0001564590-21-029539
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 52,000 2023-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046200
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 3.62M 2022-09-30 2022 Q3 10-Q 2022-11-14 0001193125-22-284622
us-gaap DeferredTaxAssetsDerivativeInstruments Deferred Tax Assets, Derivative Instruments USD 2.58M 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011035
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 31.99M 2025-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 2.77M 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046200
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2025-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 26.78M 2025-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 1.39M 2025-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 87,000 2025-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 141,000 2025-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 31.99M 2025-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap DerivativeLiabilities Derivative Liability USD 1.13M 2022-09-30 2022 Q3 10-Q 2022-11-14 0001193125-22-284622
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 1,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 0 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011035
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 2.77M 2022-09-30 2022 Q3 10-Q 2022-11-14 0001193125-22-284622
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -2.85 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.02 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-16 0001564590-21-044716
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.58 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001831868-25-000007
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.224 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Percent pure 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-16 0000950170-24-044855
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.001 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.009 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure -0.007 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046200
us-gaap EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent pure -0.004 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.023 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046200
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 5.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap GrossProfit Gross Profit USD 1.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -11.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap IncomeTaxesPaid Income Taxes Paid USD 3,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 3,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 2.74M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -2.55M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD -3,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 18,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 88,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap IncomeTaxReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount USD 95,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 4,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 275,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 519,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 1.49M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001193125-22-284622
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -59,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 1.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 2.07M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011035
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD -21,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap IncreaseDecreaseInNotesPayableCurrent Increase (Decrease) in Notes Payable, Current USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0000950170-23-063668
us-gaap IncreaseDecreaseInNotesReceivables Increase (Decrease) in Notes Receivables USD 0 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001831868-25-000007
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -235,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap IncreaseDecreaseInOtherReceivables Increase (Decrease) in Other Receivables USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046200
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -805,000 2023-01-01 2023-09-30 2023 FY 10-K 2024-04-16 0000950170-24-044855
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -542,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap InterestExpense Interest Expense USD 18,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001831868-25-000007
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 16,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap InterestIncomeOperating Interest Income, Operating USD 431,930 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001193125-22-284622
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-13 0001437749-26-016764
us-gaap InterestPayableCurrent Interest Payable, Current USD 0 2024-09-30 2024 Q3 10-Q 2024-11-13 0000950170-24-126498
us-gaap InventoryNet Inventory, Net USD 45,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 214,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap Liabilities Liabilities USD 4.84M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 5.31M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap LiabilitiesCurrent Liabilities, Current USD 4.84M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity USD 300,000 2020-11-06 2022 Q3 10-Q 2022-11-14 0001193125-22-284622
us-gaap LineOfCreditFacilityRemainingBorrowingCapacity Line of Credit Facility, Remaining Borrowing Capacity USD 95.30M 2023-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046200
us-gaap LongTermDebt Long-term Debt USD 4.14M 2023-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046200
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 574,000 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046200
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap LongTermPurchaseCommitmentAmount Long-term Purchase Commitment, Amount USD 500,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-16 0000950170-24-044855
us-gaap MalpracticeInsuranceCoverageFloor Malpractice Insurance, Coverage Floor USD 250,000 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001193125-22-284622
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 1.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -1.03M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001193125-22-284622
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -9.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -11.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 198,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap NotesPayable Notes Payable USD 574,000 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046200
us-gaap NotesPayableCurrent Notes Payable, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 0 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011035
us-gaap NotesPayableRelatedPartiesNoncurrent Notes Payable, Related Parties, Noncurrent USD 0 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011035
us-gaap NumberOfReportableSegments Number of Reportable Segments pure 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap OperatingExpenses Operating Expenses USD 13.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -11.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 60,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 241,000 2025-06-30 2025 Q2 10-Q 2025-08-13 0001831868-25-000007
us-gaap OtherAccruedLiabilitiesCurrentAndNoncurrent Other Accrued Liabilities USD 195,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap OtherAssets Other Assets USD 736,000 2025-06-30 2025 Q2 10-Q 2025-08-13 0001831868-25-000007
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 343,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap OtherIncome Other Income USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046200
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -191,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001831868-25-000007
us-gaap OtherOwnershipInterestsOfferingCosts Other Ownership Interests, Offering Costs USD 518,402 2022-06-30 2022 Q2 10-Q 2022-08-16 0001564590-22-029552
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 0 2023-12-31 2023 FY 10-K 2024-04-16 0000950170-24-044855
us-gaap PaymentsForDerivativeInstrumentFinancingActivities Payments for Derivative Instrument, Financing Activities USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-16 0000950170-24-044855
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 2.41M 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-11-14 0001193125-22-284622
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap PreferredStockValueOutstanding Preferred Stock, Value, Outstanding USD 0 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046200
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 755,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 101.14M 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-06 0001564590-22-013725
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 1.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 1.09M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046200
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 767,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 2.82M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001193125-22-284622
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -5.77M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001831868-25-000007
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 541,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 8.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -163.49M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 1.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap RevenueRemainingPerformanceObligation Revenue, Remaining Performance Obligation, Amount USD 550,000 2024-06-30 2024 Q2 10-Q 2024-08-13 0000950170-24-096356
us-gaap SettlementLiabilitiesCurrent Settlement Liabilities, Current USD 200,000 2023-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046200
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 155,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 412.68M 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011035
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 145,365 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011035
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 2.46 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011035
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 7,973 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011035
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 153,504 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011035
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Other Increases (Decreases) in Period shares 41,338 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011035
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 751.85M 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011035
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 244,792 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011035
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 1.84 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011035
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 10 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011035
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0.55 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011035
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Other Share Increase (Decrease) in Period, Weighted Average Exercise Price USD/shares 1.84 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011035
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 469,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.04 2024-06-07 2025 Q2 10-Q 2025-08-13 0001831868-25-000007
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 826,000 2024-04-01 2024-06-30 2025 Q2 10-Q 2025-08-13 0001831868-25-000007
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments USD 5.99M 2022-01-01 2022-12-31 2023 FY 10-K 2024-04-16 0000950170-24-044855
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 210,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 539,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 0 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 73,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap StockRedeemedOrCalledDuringPeriodValue Stock Redeemed or Called During Period, Value USD -105.57M 2021-01-01 2021-03-31 2022 Q3 10-Q 2022-11-14 0001193125-22-284622
us-gaap TemporaryEquityAccretionToRedemptionValue Temporary Equity, Accretion to Redemption Value USD 1.28M 2022-07-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001193125-22-284622
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 1.07M 2025-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2022-09-30 2022 Q3 10-Q 2022-11-14 0001193125-22-284622
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 127,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued Unrecognized Tax Benefits, Interest on Income Taxes Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap UnrecognizedTaxBenefitsPeriodIncreaseDecrease Unrecognized Tax Benefits, Period Increase (Decrease) USD 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001193125-22-284622
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 3.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001437749-26-009797
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 2.70M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 9.98M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001831868-25-000007
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 4.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036392

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →